在基于胚胎PGT-A结果的原因不明的复发性妊娠损失的夫妇中识别神秘平衡转位

Shuo Li1,2,3,4,5, Hongchang Li1,2,3,4,5, Yuan Gao1,2,3,4,5

  • 1Center for Reproductive Medicine, Cheeloo College of Medicine, Shandong University, Jinan, China.

概括

平衡转位 (BTs) 经常错过在无法解释的重复性妊娠损失 (uRPL) 病例,尽管正常的型. 伴侣配对测序 (MPseq) 和前植入性形瘤遗传测试 (PGT-A) 可以识别这些神秘的遗传变异.

相关概念视频

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...